President Trump announced he is withdrawing the previous nomination for the next US surgeon general and tapping Dr Nicole ...
Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with HF across the ejection fraction (EF) spectrum.
The US Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials.
Fixed-pressure PAP using manual titration is more effective than auto-adjusting PAP for blood pressure control in hypertensive patients with OSA.
Pharmacogenomics-guided regimens improve BP control and optimize medication usage in patients with hypertension without increasing adverse events.
Simultaneous heart-kidney transplantation offers better long-term survival than isolated heart transplantation for patients ...
Obesity, hypertension, hyperlipidemia, obstructive sleep apnea, and hypothyroidism are independent metabolic risk factors for MASLD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results